← Back
$NRIX All transactions

Nurix Therapeutics, Inc.

A

$ Value

$0

Shares

42,875

Price

$0

Filed

Feb 10

Insider

Name

van Houte Hans

Title

Chief Financial Officer

CIK

0001817217

Roles

Officer

Transaction Details

Transaction Date

2026-02-10

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

42,875

Footnotes

The stock option vests as to 1/36 of the total shares monthly beginning March 10, 2026, until the option is fully vested on February 9, 2029, subject to the Reporting Person's provision of service to the Issuer on each vesting date. | Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. | The RSUs will vest as to 1/12 of the total award quarterly over three years, with the first quarterly increment vesting on July 30, 2026, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting. | RSUs do not expire; they either vest or are canceled prior to the vest date.

Filing Info

Accession No.

0001817217-26-000004

Form Type

4

Issuer CIK

0001549595

van Houte Hans's History

Date Ticker Type Value
2026-02-10 NRIX A $0
2026-02-10 NRIX A $0
2026-01-30 NRIX M $0
2026-01-30 NRIX M $0
2026-01-30 NRIX M $0
2026-01-30 NRIX M $0
2026-01-30 NRIX $59K
2026-01-30 NRIX $1K
2026-01-30 NRIX M $0
2026-01-30 NRIX M $0

Other Insiders at NRIX (90d)

Insider Bought Sold Last
SANDS ARTHUR T
President, CEO
2026-02-10
Hansen Gwenn
Chief Scientific Officer
$81K 2026-02-10
Ring Christine
Chief Legal Officer
$561K 2026-04-02
van Houte Hans
Chief Financial Officer
$61K 2026-02-10